Qiuli Xu

机构：Chinese PLA General Hospital · ORCID：0009-0001-7558-1191

发表论文 23 篇 · 总被引 357 次 · h-index 10

代表论文

• Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer (2020 · Cancer Letters · 被引 119)
• Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction (2013 · Placenta · 被引 64)
• ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages (2024 · Journal of Experimental & Clinical Cancer Research · 被引 47)
• Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer (2021 · OncoTargets and Therapy · 被引 24)
• Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis (2021 · Frontiers in Oncology · 被引 20)
• STING mediates LPS-induced acute lung injury by regulating ferroptosis (2024 · Experimental Cell Research · 被引 19)